Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Guelph

$27,000.00

Development of an adeno-associated virus-based lung gene therapy for surfactant protein C dysfunction

EF 2025-26

Résumé
Surfactant protein C (SPC) is a protein required for normal human lung function. Mutations in the gene encoding SPC result in the production of a toxic version of SPC. Although uncommon, this toxic SPC causes injury and scarring in the lung that leads to lung dysfunction and death in severe cases. Currently there are no easily producible animal models of lung disease caused by mutant SPC that can be used to study the disease. There is also no cure for individuals with moderate to severe disease. I propose to use adeno-associated virus (AAV) to address both the lack of animal models and the lack of treatments. AAV is a virus that does not cause disease in humans. Instead, it can be used as a vehicle to deliver the correct copy of a gene into individuals that have a genetic mutation causing disease. In this case, I will first deliver an AAV vector that encodes toxic SPC into mice. These mice will produce toxic SPC in their lungs and exhibit the disease progression seen in humans, thus creating an animal model of SPC dysfunction. Next, I will manufacture and deliver a second dual-purpose AAV vector that 1) eliminates production of toxic SPC and 2) establishes production of normal SPC. Therefore, this project will create an accessible mouse model of SPC-mediated lung disease that other researchers can use to investigate this disease. More importantly, this project aims to develop a long-lasting treatment for individuals and families suffering from this devastating condition.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573073
Name
Yang Cici
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of an adeno-associated virus-based lung gene therapy for surfactant protein C dysfunction
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Adeno-Associate Virus; Gene Therapy; Lung Disease; Surfactant Protein C
Abstract
Surfactant protein C (SPC) is a protein required for normal human lung function. Mutations in the gene encoding SPC result in the production of a toxic version of SPC. Although uncommon, this toxic SPC causes injury and scarring in the lung that leads to lung dysfunction and death in severe cases. Currently there are no easily producible animal models of lung disease caused by mutant SPC that can be used to study the disease. There is also no cure for individuals with moderate to severe disease. I propose to use adeno-associated virus (AAV) to address both the lack of animal models and the lack of treatments. AAV is a virus that does not cause disease in humans. Instead, it can be used as a vehicle to deliver the correct copy of a gene into individuals that have a genetic mutation causing disease. In this case, I will first deliver an AAV vector that encodes toxic SPC into mice. These mice will produce toxic SPC in their lungs and exhibit the disease progression seen in humans, thus creating an animal model of SPC dysfunction. Next, I will manufacture and deliver a second dual-purpose AAV vector that 1) eliminates production of toxic SPC and 2) establishes production of normal SPC. Therefore, this project will create an accessible mouse model of SPC-mediated lung disease that other researchers can use to investigate this disease. More importantly, this project aims to develop a long-lasting treatment for individuals and families suffering from this devastating condition.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yang, Cici
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~